These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Ebastine in perennial allergic rhinitis.
    Author: Picado Vallés C, Cadahia García A, Cisteró Bahima A, Cano Cantudo L, Sanz Amaro A, Zayas Sanza JM.
    Journal: Ann Allergy; 1991 Dec; 67(6):615-8. PubMed ID: 1684273.
    Abstract:
    Oral ebastine, 10 mg once daily for seven days, and placebo were compared as treatment for active perennial allergic rhinitis in 151 patients in a multicenter, randomized, double-blind trial. Ebastine treatment produced a significant reduction in the incidence and severity of most symptoms associated with perennial rhinitis. Tolerability was similar in the two treatment groups. The incidences of drowsiness and dry mouth were not more frequent in the patients treated with the active drug.
    [Abstract] [Full Text] [Related] [New Search]